Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Delirium Companies

ID: MRFR/Pharma/4394-CR
128 Pages
Vikita Thakur
Last Updated: March 27, 2026
Delirium is typically a medical term referring to a state of severe confusion and rapid changes in brain function, often caused by illness, medication, or other factors. However, if you are referring to a fictional or specific company named "Delirium," I would need more context or details to provide an accurate description.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Delirium Market

Delirium market
ย 

Latestย Deliriumย Companiesย Updates:

Pfizer Continued marketing of Aricept (donepezil) for the treatment of delirium in dementia patients, emphasizing its safety and efficacy profile.

AstraZeneca Collaboration with the Delirium Consortium to develop and validate new diagnostic tools for delirium in critically ill patients.

Cognito Therapeutics Phase 2b clinical trial results for its investigational drug, CNT001, showed improvements in cognitive function and delirium symptoms in older adults with mild cognitive impairment.

Philips Healthcare Development of AI-powered vital sign monitoring systems to detect early signs of delirium in critically ill patients.

List ofย Deliriumย Key companies in the market:

  • Otsuka Pharmaceutical Co., Ltd (Japan)
  • Mylan N.V (US)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Zydus Group (India)
  • Glenmark Pharmaceuticals Ltd (India)
  • Pfizer (India)
  • Mylan N.V (US)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Glenmark Pharmaceuticals Ltd (India)